Emergent BioSolutions Inc.
EBS
Price:
$7.52
Market Cap:
$397.86M
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylax...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-11-15
Stock Exchange
NYSE
Ticker
EBS
The ROE as of September 2024 (TTM) for Emergent BioSolutions Inc. (EBS) is -98.39%
According to Emergent BioSolutions Inc.’s latest financial reports and current stock price. The company's current ROE is -98.39%. This represents a change of 234.38% compared to the average of -29.42% of the last 4 quarters.
Emergent BioSolutions Inc. (EBS) Historical ROE (quarterly & annually)
How has EBS ROE performed in the past?
The mean historical ROE of Emergent BioSolutions Inc. over the last ten years is -5.35%. The current -98.39% ROE has changed 1.74% with respect to the historical average. Over the past ten years (40 quarters), EBS's ROE was at its highest in in the December 2020 quarter at 12.81%. The ROE was at its lowest in in the June 2024 quarter at -73.29%.
Average
-5.35%
Median
7.66%
Minimum
-117.13%
Maximum
21.13%
Emergent BioSolutions Inc. (EBS) ROE by Quarter and Year
Discovering the peaks and valleys of Emergent BioSolutions Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 623.80%
Maximum Annual ROE = 21.13%
Minimum Annual Increase = -219.36%
Minimum Annual ROE = -117.13%
| Year | ROE | Change |
|---|---|---|
| 2023 | -117.13% | 623.80% |
| 2022 | -16.18% | -219.36% |
| 2021 | 13.56% | -35.85% |
| 2020 | 21.13% | 322.09% |
| 2019 | 5.01% | -19.27% |
| 2018 | 6.20% | -31.49% |
| 2017 | 9.05% | 4.25% |
| 2016 | 8.68% | -8.83% |
| 2015 | 9.53% | 43.42% |
| 2014 | 6.64% | 4.44% |
Emergent BioSolutions Inc. (EBS) Average ROE
How has EBS ROE performed in the past?
The current ROE of Emergent BioSolutions Inc. (EBS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-39.92%
5-year avg
-18.72%
10-year avg
-5.35%
Emergent BioSolutions Inc. (EBS) ROE vs. Peers
How is EBS’s ROE compared to its peers?
Emergent BioSolutions Inc.’s ROE is less than Zoetis Inc. (46.65%), less than PetIQ, Inc. (5.54%), less than Bausch Health Companies Inc. (3.27%), less than Neurocrine Biosciences, Inc. (14.86%), greater than Akanda Corp. (-543.35%), less than Lifecore Biomedical, Inc. (26.37%), less than Prestige Consumer Healthcare Inc. (12.68%), greater than Intra-Cellular Therapies, Inc. (-11.48%), less than Indivior PLC (812.66%), less than Alkermes plc (22.66%), greater than Cumberland Pharmaceuticals Inc. (-34.74%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Collegium Pharmaceutical, Inc. (49.14%), greater than DURECT Corporation (-148.61%),
| Company | ROE | Market cap |
|---|---|---|
| 46.65% | $85.73B | |
| 5.54% | $905.94M | |
| 3.27% | $2.28B | |
| 14.86% | $12.13B | |
| -543.35% | $2.11M | |
| 26.37% | $147.38M | |
| 12.68% | $3.68B | |
| -11.48% | $7.77B | |
| 812.66% | $2.89B | |
| 22.66% | $4.42B | |
| -34.74% | $18.25M | |
| -52.42% | $2.21B | |
| 49.14% | $1.20B | |
| -148.61% | $48.73M |
Build a custom stock screener for Emergent BioSolutions Inc. (EBS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emergent BioSolutions Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Emergent BioSolutions Inc. (EBS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Emergent BioSolutions Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Emergent BioSolutions Inc.'s ROE?
How is the ROE calculated for Emergent BioSolutions Inc. (EBS)?
What is the highest ROE for Emergent BioSolutions Inc. (EBS)?
What is the 3-year average ROE for Emergent BioSolutions Inc. (EBS)?
What is the 5-year average ROE for Emergent BioSolutions Inc. (EBS)?
How does the current ROE for Emergent BioSolutions Inc. (EBS) compare to its historical average?